Breckenridge Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?
BRECKENRIDGE has forty-four approved drugs.
There are four tentative approvals on BRECKENRIDGE drugs.
Summary for Breckenridge
US Patents: | 0 |
Tradenames: | 43 |
Ingredients: | 43 |
NDAs: | 44 |
Patent Litigation for Breckenridge: | See patent lawsuits for Breckenridge |
PTAB Cases with Breckenridge as petitioner: | See PTAB cases with Breckenridge as petitioner |
Drugs and US Patents for Breckenridge
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge | PIROXICAM | piroxicam | CAPSULE;ORAL | 208991-001 | Feb 21, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Breckenridge | CABAZITAXEL | cabazitaxel | SOLUTION;INTRAVENOUS | 207619-001 | Jun 23, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Breckenridge | ALPRAZOLAM | alprazolam | TABLET;ORAL | 207507-001 | Jul 9, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Breckenridge | EPLERENONE | eplerenone | TABLET;ORAL | 208283-002 | Sep 14, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Breckenridge | ENTECAVIR | entecavir | TABLET;ORAL | 208721-002 | Mar 15, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Breckenridge | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 209063-003 | Nov 26, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Breckenridge | OMEPRAZOLE | omeprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 203481-001 | Jul 3, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.